Comparison of Radiofrequency Ablation With Concomitant or Staged Treatment for Tributary Varicose Veins

February 26, 2026 updated by: Sir Run Run Shaw Hospital

Comparison of Concomitant or Staged Treatment of Tributary Veins for Lower Extremity Varicose Veins: A Multicenter Randomized Controlled Study

The purpose of this clinical trial is to know which is better to treat the branch vein at the same time or in stages during radiofrequency ablation. The main questions it aims to answer are:

Does the patient who did not treat the branch vein in the first stage of operation need to intervene again? Are there any differences in patients' indexes between the two surgical strategies?

Participants will:

Radiofrequency ablation with or without foam sclerosing agent therapy One week, three months and six months after operation, go to the clinic for a reexamination.

Record their symptoms

Study Overview

Study Type

Interventional

Enrollment (Estimated)

206

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Anhui
      • Bengbu, Anhui, China
        • The First Affiliated Hospital of Bengbu Medical University
        • Contact:
          • Zhaowen Yu
          • Phone Number: 8613309651876
    • Beijing Municipality
      • Beijing, Beijing Municipality, China
        • Peking University Third Hospital
        • Contact:
          • Changming Wang
      • Beijing, Beijing Municipality, China
        • Peking University International Hospital
        • Contact:
          • Qian Wang
    • Guangxi
      • Nanning, Guangxi, China
        • The First Affiliated Hospital of Guangxi University of Chinese Medicine
        • Contact:
          • Yaochang Luo
          • Phone Number: 8615907713918
      • Nanning, Guangxi, China
        • Guangxi Zhuang Autonomous Region People's Hospital
        • Contact:
          • Lei Yu
          • Phone Number: 8613387719938
    • Hainan
      • Haikou, Hainan, China
        • Hainan Provincial Hospital of Traditional Chinese Medicine
        • Contact:
          • Chuang Wang
          • Phone Number: 8613514808066
    • Henan
      • Zhengzhou, Henan, China
        • Zhengzhou Central Hospital
        • Contact:
          • Bin Song
      • Zhoukou, Henan, China
        • Zhoukou Central Hospital
        • Contact:
          • Xianwei Qi
    • Hunan
      • Chenzhou, Hunan, China
        • The First People's Hospital of Chenzhou
        • Contact:
          • Yide Zheng
    • Jiangsu
      • Huai'an, Jiangsu, China
        • Huai'an First People's Hospital
        • Contact:
          • Gang Xu
          • Phone Number: 8618851258521
      • Nanjing, Jiangsu, China
        • Jiangsu Province Hospital of Traditional Chinese Medicine
        • Contact:
          • Weihua Jiang
          • Phone Number: 8613770662060
    • Jiangxi
      • Nanchang, Jiangxi, China
        • The Second Affiliated Hospital of Nanchang University
        • Contact:
          • Weimin Zhou
          • Phone Number: 8613870658585
    • Liaoning
      • Dalian, Liaoning, China
        • The First Affiliated Hospital of Dalian Medical University
        • Contact:
          • Ming Qi
          • Phone Number: 8618098875991
      • Shenyang, Liaoning, China
        • The First Affiliated Hospital of China Medical University
        • Contact:
          • Jian Zhang
    • Shandong
      • Dezhou, Shandong, China
        • Dezhou People's Hospital
        • Contact:
          • Haiqing Wang
          • Phone Number: 8613053420366
      • Yantai, Shandong, China
        • Yantai Yuhuangding Hospital
        • Contact:
          • Lubin Li
          • Phone Number: 8618653587355
      • Zibo, Shandong, China
        • Zibo First Hospital
        • Contact:
          • Tong Liu
          • Phone Number: 8613156987626
    • Zhejiang
      • Hangzhou, Zhejiang, China
        • The Second Affiliated Hospital, Zhejiang University School of Medicine
        • Contact:
          • Zhenjie Liu
      • Hangzhou, Zhejiang, China, 310000
        • Sir Run Run Shaw Hospital, Zhejiang University School of Medicine
        • Contact:
        • Contact:
          • Yuefeng Zhu
        • Principal Investigator:
          • Yuefeng Zhu, Archiater
        • Sub-Investigator:
          • Huanhuan Chen, Attending physician
        • Sub-Investigator:
          • Qiang Zheng, Certified doctor
      • Hangzhou, Zhejiang, China
        • Hangzhou Third People's Hospital
        • Contact:
          • Luyang Meng
          • Phone Number: 13777831991
      • Shaoxing, Zhejiang, China
        • Affiliated Hospital of Shaoxing University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

aged between 18 and 80 years; primary unilateral lower limb GSV varicose; hemodynamic classification I and III involvement in tributary veins, tributary veins originating within 15 cm inferior to the knee joint; clinical grade C2-C4; primary trunk diameter of GSV in thigh segment≥3mm to ≤ 15 mm; agree to participate in this study and voluntarily sign an informed consent form.

Exclusion Criteria:

Body Mass Index (BMI) ≥35kg/m2; severe tortuosity or tight adherence of the trunk of the GSV to the skin in the thigh; history of previous varicose vein surgery on the ipsilateral lower limb (investigator allows to be controlled); previous deep vein thrombosis and/or calf muscle venous thrombosis; uncorrectable coagulation disorders or significant blood abnormalities (platelets≤30×109/L); allergy to lidocaine or sclerosing agents; ankle-brachial index (ABI) <0.6 and/or absolute ankle pressure <60mmHg; pregnancy or lactation, or intend to have a child in the next year; participation in other clinical trials; anterior saphenous vein start diameter>3.5mm; any other patients investigator considers improper to participate in this study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: A
The patient is placed in the supine position, and then a DUS examination of the GSV in the affected limbs will be performed. At the appropriate site, local anesthesia will be performed, and the ultrasound-guided Seldinger technique will be used to puncture the main trunk of the GSV 10cm above and below the knee joint. When the needle puncture is successful, we will insert the guidewire, and a 7F vascular sheath (Terumo) will be inserted along the guidewire. Then, we will insert the radiofrequency catheter and advanced the tip to approximately 2 cm at the junction of the saphenofemoral vein, where it will be left in place. Under ultrasound guidance, the needle will be tightly attached to the GSV sheath, and an anesthetic solution will be injected to treat the swelling until the junction of the saphenofemoral vein will be reached. Then, we will secure the tip of the radiofrequency catheter and switch on the radiofrequency generator and ablated the primary trunk of the GSV in segments.
Placebo Comparator: B
While the experimental group receives ablation alone, the control group received 1% polidocanol foam sclerosant injection and/or point excision treatment for the pre-marked calf segment branches of the GSV after ablation treatment. Both groups will wear elastic bandages for 24 hours postoperatively, followed by thigh-length class II compression stockings for 1 week after bandage removal.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
The re-intervention rate
Time Frame: 1 week, 3 months and 6 months after surgery
1 week, 3 months and 6 months after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Treatment cost
Time Frame: 6 months after surgery
According to the statistics of hospital charging system
6 months after surgery
Success rate of varicose vein closure
Time Frame: 1 week, 3 months and 6 months after surgery
1 week, 3 months and 6 months after surgery
Operation time
Time Frame: During the operation
During the operation
Number of incisions
Time Frame: During the operation
During the operation
Tumescent anesthesia solution dosage
Time Frame: During the operation
During the operation
The amount of intraoperative bleeding
Time Frame: During the operation
During the operation
AVVQ score
Time Frame: Before surgery, 1 week, 3 months and 6 months after surgery
The Aberdeen varicose vein questionnaire. The score range is 0-100, and the higher the score, the worse the result.
Before surgery, 1 week, 3 months and 6 months after surgery
VAS score
Time Frame: Before surgery, 1 week, 3 months and 6 months after surgery
Visual analogue scale. The score range is 0-10, and the higher the score, the worse the result.
Before surgery, 1 week, 3 months and 6 months after surgery
VCSS score
Time Frame: Before surgery, 1 week, 3 months and 6 months after surgery
Venous clinical severity score. The score range is 0-30, and the higher the score, the worse the result.
Before surgery, 1 week, 3 months and 6 months after surgery
Postoperative complications
Time Frame: 1 week, 3 months and 6 months after surgery
1 week, 3 months and 6 months after surgery
Time to return to regular work
Time Frame: 1 week after surgery
1 week after surgery
Patient satisfaction
Time Frame: During the operation and 6 months after surgery
Include two question: "The quality of treatment that you received was good?" "The treatment that you received fulfilled your expectations?"
During the operation and 6 months after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

March 1, 2026

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Study Registration Dates

First Submitted

November 17, 2025

First Submitted That Met QC Criteria

February 26, 2026

First Posted (Actual)

March 3, 2026

Study Record Updates

Last Update Posted (Actual)

March 3, 2026

Last Update Submitted That Met QC Criteria

February 26, 2026

Last Verified

November 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 2025-2700-01

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Varicose Veins of Lower Limb

Clinical Trials on Staged surgery group

Subscribe